First Keller Healthcare provides medically supervised weight loss. The medical professionals, and the team take an individualized approach to patient health and wellness, knowing no single diet or weight-loss strategy works for all. The team treats the whole patient, not just their symptoms or lab results.

Weight loss management at First Keller Healthcare utilizes vitamin injections, supplements, FDA approved prescription weight loss medications, and effective diet plans to help patients reach their weight goals.

The weight Loss Therapy at First Keller Healthcare focuses on health and wellness, providing alternative and preventive health treatments such as anti-aging therapy, bioidentical hormone replacement therapy, and intravenous (IV) vitamin therapy.

For the patient’s convenience, the weight loss therapy also offers telemedicine appointments. Call First Keller Healthcare or schedule a consultation online today.

No single weight-loss therapy program works for everyone. First Keller Healthcare, and the team provides weight loss management, developing a strategy that helps you reach your ultimate weight goals. Call the office or schedule your weight loss management appointment online today

request an appointment


The U.S. Food and Drug Administration approved Wegovy (semaglutide) injection once a week for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This weekly subcutaneous injection is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014. Some are calling it the new gastric by-pass in a syringe.

Semaglutide works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. The medication dose must be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.

The most common side effects of semaglutide include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, abdominal distension, belching, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, and gastroesophageal reflux disease.

The prescribing information for semaglutide contains a boxed warning to inform healthcare professionals and patients about the potential risk of thyroid C-cell tumors. Semaglutide should not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with a rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Semaglutide should not be used in patients with a history of severe allergic reactions to semaglutide. Patients should stop semaglutide immediately and seek medical help if a severe allergic reaction is suspected. Semaglutide also contains warnings for inflammation of the pancreas (pancreatitis), gallbladder problems (including gallstones), low blood sugar, acute kidney injury, diabetic retinopathy (damage to the eye’s retina), increased heart rate and suicidal behavior or thinking. If semaglutide is used with insulin or a substance that causes insulin secretion, patients should speak to their health care provider about potentially lowering the dose of insulin or the insulin-inducing drug to reduce the risk of low blood sugar.

It’s not known whether it’s safe to use semaglutide during pregnancy. The drug’s manufacturer recommends stopping semaglutide at least 2 months before trying to become pregnant. This clinic will not prescribe semaglutide to patients who are pregnant or breast feeding (no exceptions.)

Dosing schedule:

Week 1 – 4: Dose 0.25 mg Week 13 – 16 Dose 1.7 mg

Week 5 – 8: Dose 0.5 mg Week 17 and onward Dose 2.4 mg (Maintenance)

Week 9 – 12: Dose 1 mg


Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is composed of 39 amino acids and is an analog of the gastric inhibitory polypeptide. It enhances the insulin response, suppresses glucagon secretion, promotes satiety and improves insulin sensitivity. Tirzepatide works by helping the patient feel full on less food and slowing the passage of food through the digestive tract.

Vitamin B12 is a water-soluble vitamin that plays essential roles in red blood cell creation, cell metabolism, nerve function and production of DNA. It also works as a coenzyme in the conversion of protein and fat into energy.

Common side effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Stomach pain
  • Constipation
  • Upset stomach

Who should not take Tirzepatide?

Given the theoretical risk, Tirzepatide should be avoided in those with a personal or family history of medullary thyroid carcinoma. Patients with a history of MEN 2 (multiple endocrine neoplasia syndrome type-2) should also avoid Tirzepatide. Furthermore, patients who experience a hypersensitivity reaction should avoid using Tirzepatide any further. Other relative contraindications also exist, such as gallbladder disease or diabetic retinopathy.

Tirzepatide should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) and protected from light. It can be stored at room temperature for 21 days, if needed.

Pregnancy Use:
It’s not known whether it’s safe to use tirzepatide during pregnancy. The drug’s manufacturer recommends stopping tirzepatide at least 2 months before trying to become pregnant. This clinic will not prescribe tirzepatide to patients who are pregnant or breast feeding (no exceptions.)

Intravenous (IV) vitamin therapy is a safe and effective way to deliver essential nutrients and fluids into your bloodstream. The medical providers, and the team, provide IV vitamin therapy treatments to meet a wide range of health needs and goals. Find out more about IV vitamin therapy and how it can benefit your health by calling the office or scheduling an appointment online today.